| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.4 |